Drug-induced injury in the gastrointestinal tract: Clinical and pathologic considerations

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 8, 2007, Pages 442-453

  Pusztaszeri, Marc P ^a   Genta, Robert M ^b   Cryer, Byron L ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; COCAINE; COLCHICINE; CORTICOSTEROID; CYTARABINE; ERGOTAMINE; ESTROGEN; FERROUS SULFATE; FLUOROURACIL; FLUTAMIDE; GOLD DERIVATIVE; IRINOTECAN; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; POTASSIUM CHLORIDE; PROTON PUMP INHIBITOR; QUINIDINE; RANITIDINE; TETRACYCLINE; TICLOPIDINE; UNINDEXED DRUG; VALPROIC ACID; VASOPRESSIN; VINCRISTINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AWARENESS; COLITIS; DIAPHRAGM DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG FORMULATION; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DISEASE; ESOPHAGUS HEMORRHAGE; ESOPHAGUS INJURY; ESOPHAGUS PERFORATION; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; GASTROENTEROLOGY; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; INTERPERSONAL COMMUNICATION; INTESTINE NECROSIS; INTESTINE ULCER; MALACOPLAKIA; MEDICAL SPECIALIST; MICROSCOPIC COLITIS; MORBIDITY; MORTALITY; PATHOLOGIST; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RECTOVAGINAL FISTULA; RECTUM HEMORRHAGE; RECTUM ULCER; REVIEW; RISK ASSESSMENT; STOMACH EROSION; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; MORBIDITY; SEVERITY OF ILLNESS INDEX; WORLD HEALTH;

EID: 34547689191     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0896     Document Type: Review

References (85)

1. Fennerty MB (2001) NSAID-related gastrointestinal injury. Evidence-based approach to a preventable complication. Postgrad Med 110: 87-88, 91-94
2. Singh G (1998) Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 105: 31S-38S
3. Abid S et al. (2005) Pill-induced esophageal injury: Endoscopic features and clinical outcomes. Endoscopy 37: 740-744
4. Kikendall JW (1999) Pill esophagitis. J Clin Gastroenterol 28 298-305
5. Kikendall JW (1999) Pill-induced asophageal injury. In The Esophagus edn 3, 527-637 (Eds Castell DO and Richter JE) Philadelphia: Lippincott Williams & Wilkins
6. Cameron RB (1997) Esophagitis dissecans superficialis and alendronate: case report. Gastrointest Endosc 46: 562-563
7. Adachi W et al. (1998) A case of pill-induced esophagitis with mucosal dissection. Diagn Ther Endosc 4: 149-153
8. Semble EL et al. (1989) Nonsteroidal anti-inflammatory drugs and esophageal injury. Semin Arthritis Rheum 19: 99-109
9. Gulsen MT et al. (2005) Cyproterone acetate and ethinylestradiol-induced pill oesophagitis: A case report. Int J Clin Pract Suppl 147: 79-81
10. D'Agostino L et al. (2004) A life-threatening case of stenosing pill hypopharynx-oesophagitis caused by a tamsulosin capsule. Dig Liver Dis 36: 632-634
11. Maekawa T et al. (2001) Pill-induced esophagitis caused by lansoprazole. J Gastroenterol 36. 790-791
12. Abraham SC et al. (1999) Alendronate associated esophageal injury: pathologic and endoscopic features. Mod Pathol 12: 1152-1157
13. de Groen PC et al. (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335: 1016-1021
14. Lufkin EG et al. (1994) Pamidronate: An unrecognized problem in gastrointestinal tolerability. Osteoporos Int 4: 320-322
15. Quinn CM et al. (1993) Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology 23: 341-348
16. Sobala GM et al. (1990) Reflux gastritis in the intact stomach. J Clin Pathol 43: 303-306
17. Graham DY and Smith JL (1988) Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 83: 1081-1084
18. Schoenfeld P et al. (1999) Nonsteroidal anti-inflammatory drug-associated gastrointestinal complications - guidelines for prevention and treatment. Aliment Pharmacol Ther 13: 1273-1285
19. Cryer B (2001) Nonsteroidal anti-inflammatory drug gastrointestinal toxicity. Curr Opin Gastroenterol 17: 503-512
20. Jones R (2002) Efficacy and safety of COX 2 inhibitors. BMJ 325 607-608
21. Deeks JJ et al. (2002) Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials. BMJ 325: 619
22. Bombardier C et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343: 1520-1528
23. Mamdani M et al. (2002) Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 325: 624
24. Silverstein FE et al. (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123: 241-249
25. Chan FK et al. (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347: 2104-2110
26. Scheiman JM et al. (2006) Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 101: 701-710
27. Driman DK et al. (1996) Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci 41: 2039-2047
28. Rindi G et al. (2005) European Rabeprazole Study Group. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. Eur J Gastroenterol Hepatol 17: 559-566
29. Choudhry U and Boyce HW Jr (1998) Proton pump inhibitor-associated gastric polyps: A retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol 110: 615-621
30. Sapoznikov B et al. (2005) Minidose aspirin and gastrointestinal bleeding - a retrospective, case-control study in hospitalized patients. Dig Dis Sci 50: 1621-1624
31. Cryer B et al. (1995) Effects of very low doses of aspirin on gastric, duodenal and rectal prostaglandins and mucosal injury. Gastroenterology 108: A77
32. Reuter BK et al. (1997) Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112: 109-117
33. Somasundaram S et al. (2000) Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 14: 639-650
34. Bjamason I et al. (1984) Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs. Lancet 2: 1171-1174
35. Bjamason I et al. (1987) Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 2: 711-714
36. Bjamason I et al. (1987) Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93: 480-489
37. Morris AJ et al. (1992) Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33: 887-889
38. Kepczyk T and Kadakia SC (1995) Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia. Dig Dis Sci 40: 1283-1289
39. Lee FD (1994) Drug related pathological lesions of the intestinal tract. Histopathology 24, 303-308
40. Thiéfin G et al. (2000) Diaphragme duodénal induit par la prise d'aspirine [French]. Presse Med 29: 1351-1352
41. Cortina G et al. (1999) Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel. Am J Surg Pathol 23: 1414-1417
42. Isaacs PE et al. (1987) Mefenamic acid enteropathy. J Clin Pathol 40: 1221-1227
43. Freeman HJ (1986) Sulindac-associated small bowel lesion. J Clin Gastroenterol 8: 569-571
44. Gibson GR et al. (1992) Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med 152: 625-632
45. Kaufman JH and Taubin HL (1987) NSAID activate quiescent inflammatory bowel disease. Ann Intern Med 107: 513-516
46. Stamm C et al. (1994) Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion. Am J Gastroenterol 89: 2230-2233
47. Halter F et al. (1993) Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol 16: 74-80
48. Bridges AJ et al. (1990) Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Am J Med 89: 526-527
49. Hall RI et al. (1983) Enteritis and colitis associated with mefenamic acid. BMJ 287: 1182
50. Beaugerie L et al. (1994) Drug induced lymphocytic colitis. Gut 35: 426-428
51. Giardiello FM et al. (1990) Collagenous colitis in setting of nonsteroidal anti-inflammatory drugs and antibiotics. Dig Dis Sci 35: 257-260
52. Campbell KL and de Baux AC (1992) Non-steroidal anti-inflammatory drugs and appendicitis in patients over 50 years. Br J Surg 79: 967-968
53. Wilson RG et al. (1990) Complications of diverticular disease & non-steroidal anti-inflammatory drugs: A prospective study. Br J Surg 77: 1103-1104
54. D'Halluin PN et al. (2003) Selective COX-2 inhibitor-associated colitis: Two case reports. Gastroenterol Clin Biol 27: 932-935
55. Ghadially FN and Walley VM (1994) Melanoses of the gastrointestinal tract. Histopathology 25: 197-207
56. Byers RJ et al. (1997) Melanosis coli is associated with an increase in colonic epithelial apoptosis and not with laxative use. Histopathology 30: 160-164
57. Biggar WD et al. (1985) Malakoplakia and immunosuppressive therapy: Reversal of clinical and leukocyte abnormalities after withdrawal of prednisone and azathioprine. Am J Pathol 119: 5-11
58. Guinaudeau E et al. (2002) Colonic malacoplakia and ulcerative colitis: Report of a case. Gastroenterol Clin Biol 26: 174-177
59. Jackson CW et al. (1906) Gold induced enterocolitis. Gut 27: 452-456
60. Thomson RD et al. (2002) Lansoprazole-associated microscopic colitis: A case series. Am J Gastroenterol 97: 2908-2913
61. Beaugerie L et al. (1995) Ranitidine, diarrhoea, and lymphocytic colitis. Gut 37: 708-711
62. Feurie GE et al. (1999) Lymphocytic colitis, induced by ticlopidine. Z Gastroenterol 37: 1105-1108
63. Fernandez-Banares F et al. (2003) Collagenous and lymphocytic colitis: Evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 98: 340-347
64. Cappell MS (2004) Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 99: 1175-1190
65. Freudenberger RS et al. (1990) Intestinal infarction after intravenous cocaine administration. Ann Intem Med 113: 715-716
66. Linder JD et al. (2000). Cocaine-associated ischemic colitis. South Med J 93: 909-913
67. Stillman AE et al. (1977) Ischemic bowel disease attributable to ergot. Gastroenterology 72: 1336-1337
68. McClennan BL. (1976) Ischemic colitis secondary to premarin: Report of a case. Dis Colon Rectum 19: 618-620
69. Friedel D et al. (2001) Ischemic colitis during treatment with alosetron. Gastroenterology 120: 557-560
70. Beyer KL et al. (1991) Ischemic colitis associated with dextroamphetamine use. J Clin Gastroenterol 13: 198-201
71. Rashid A and Hamilton SR (1997) Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: An underrecognized condition. Am J Surg Pathol 21: 60-69
72. Kato S et al. (1995) Antibiotic-associated hemorrhagic colitis without Clostridium difficile toxin in children. J Pediatr 126: 1008-1010
73. Kronawitter U et al. (1997) Neutropenic enterocolitis in a patient with colorectal carcinoma: Unusual course after treatment with 5-fluorouracil and leucovorin - a case report. Cancer 80: 656-660
74. Petruzell GJ et al. (1990) Neutropenic enterocolitis: A new complication of head and neck cancer chemotherapy. Anch Otolaryngol Head Neck Surg 116: 209-211
75. Eckardt VF et al. (1986) Anorectal ergotism: Another cause of solitary rectal ulcers. Gastroenterology 91: 1123-1127
76. Gizzi G et al. (1990) Ano-rectal lesions in patients taking suppositories containing non-steroidal anti-Inflammatory drugs (NSAID). Endoscopy 22: 146-148
77. Van Gossum A et al. (1993) Anorectal stenosis in patients with prolonged use of suppositories containing paracetamol and acetylsalicylic acid. Dig Dis Sci 38: 1970-1977
78. de Parades V et al. (1996) Complications anorectales et coliques des suppositoires et des lavements [French]. Gastroenterol Clin Biol 20: 446-452
79. Eckstein RP and Symons P (1996) Iron tablets cause histopathologically distinctive lesions in mucosal biopsies of the stomach and oesophagus. Pathology 28: 142-145
80. Hruban RH et al. (1989) Taxol toxicity: Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer 15: 1944-1950
81. Finger JE and Headington JT (1963) Colchicine-induced epithelial altypia. Am J Clin Pathol 40: 605-609
82. Iacobuzio-Donahue CA et al. (2001) Colchicine toxicity: Distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol 25: 1067-1073
83. Gibson RJ et al. (2003) Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18: 1095-1100
84. Sandmeier D et al. (2005) Irinotecan-induced colitis. Int J Surg Pathol 13: 215-218
85. Sears S et al. (1999) Irinotecan (CPT-11) induced colitis: Report of a case and review of Food and Drug Administration MEDWATCH reporting. Gastrointest Endosc 50: 841-844